A Rough Guide to Spotting Bad Science
Compound Interest
How to tell if a merger rumor will come true
Craig Silverman (Quartz)
Should Med School Leaders Serve on Pharma Boards?
John LaMattina (Forbes)
From Luddite to Guru: a Cynic’s Guide to Twitter for Biotech Professionals
TCP Innovations (Drug Baron blog)
Advice on making the most of the biotech community on Twitter, complete with a recommended list of followers.
These next two links are from brand-new blogs from valuable members of the Biotech Twitterverse: @bradloncar and @vikramkhanna_. Be sure to check out their websites and all of the other key resources highlighted on the BiotechDueDiligence Links page.
In this market, survival first is the name of the game
Brad Loncar (Loncar Blog)
Dismantling the biotech IPO bubble thesis
Vikram Khanna (BiotechVK)
Compound Interest
How to tell if a merger rumor will come true
Craig Silverman (Quartz)
Should Med School Leaders Serve on Pharma Boards?
John LaMattina (Forbes)
From Luddite to Guru: a Cynic’s Guide to Twitter for Biotech Professionals
TCP Innovations (Drug Baron blog)
Advice on making the most of the biotech community on Twitter, complete with a recommended list of followers.
These next two links are from brand-new blogs from valuable members of the Biotech Twitterverse: @bradloncar and @vikramkhanna_. Be sure to check out their websites and all of the other key resources highlighted on the BiotechDueDiligence Links page.
In this market, survival first is the name of the game
Brad Loncar (Loncar Blog)
Dismantling the biotech IPO bubble thesis
Vikram Khanna (BiotechVK)
RSS Feed
